Stocks · Health care · Pharmaceutical Preparations

MBX Biosciences, Inc.

MBX Clue Score38
United States Fiscal year ends December CIK 0001776111 Results filed 6 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Salomon Azoulay
8 May 2026
Chief Medical Officer
Sold after exercise
15,003
$38.30
$574.61K
Salomon Azoulay
8 May 2026
Chief Medical Officer
Sold after exercise
55,000
$38.38
$2.11M

What was left out

Form 4 filings counted 24
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 2
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 274,959
History held since 13 Sep 2024